Research and Markets: The Top 10 Developers of Breakthrough Cancer Pain Medications

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/w8n8xd/the_top_10_develop) has announced the addition of the "The Top 10 Developers of Breakthrough Cancer Pain Medications" report to their offering.

Breakthrough pain has been defined as a transient exacerbation of pain that occurs either spontaneously, or in relation to a specific predictable or unpredictable trigger, despite relatively stable and adequately controlled background pain.

Studies have estimated the prevalence of breakthrough cancer pain at anywhere between 19% and 95%. In one international study of over 1,095 cancer patients, 2/3 of these patients experienced breakthrough pain.

Breakthrough pain may result in a number of physical problems, psychological problems and social complications. Hence, the presence of breakthrough pain can have a significant negative impact on the quality of life of the patient.

An American Pain Foundation Survey in January, 2010 Found That:

- 73% of cancer patients said breakthrough pain wakes them from a deep sleep at least once a month and interrupts their sleep weekly.

- 82% of cancer patients said breakthrough pain had a negative effect on their emotional health.

- 76% of cancer patients said breakthrough pain affects their ability to perform household chores.

Breakthrough pain significantly increases the utilization of healthcare services. It is estimated that the cost of caring for cancer patients who have breakthrough pain is approximately $12,000 per year compared to $2,400 for those without it.

There are many developers of pain management pharmaceuticals worldwide. This report profiles the Top 10 developers of breakthrough cancer pain medications. They are located across the globe and develop products to treat all types of breakthrough cancer pain (incident, idiopathic, end-of-dose).

Report Target Market:

1) Developers of Pain Management Pharmaceuticals

2) Drug Delivery Companies

3) Contract Research Organisations

4) Investors

5) Professional Organisations

Report Data Field Structure is as Follows:

- Company Name

- Mailing Address

- Street Address

- Telephone

- Fax

- Email

- Website

- Parent Company Name

- Year Established

- Number of Employees

- Key Executives

- Company Description

- Products

- Pipeline

- Indications

- Turnover m

- Foreign Trade

- Location Status

- Ownership

For more information visit http://www.researchandmarkets.com/research/w8n8xd/the_top_10_develop

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): 353-1-481-1716
Sector: Oncology

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): 353-1-481-1716
Sector: Oncology